Tenet Healthcare (NYSE:THC) Director Roy Blunt Sells 600 Shares

Tenet Healthcare Corporation (NYSE:THC) Director Roy Blunt sold 600 shares of the business’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total transaction of $157,608.00. Following the sale, the director directly owned 4,589 shares in the company, valued at $1,205,438.52. This trade represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $262.75 on Friday. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.41 and a quick ratio of 1.35. The business has a 50-day moving average of $200.19 and a 200-day moving average of $201.39. The stock has a market capitalization of $21.16 billion, a price-to-earnings ratio of 10.13, a PEG ratio of 0.98 and a beta of 1.23. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $265.32.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The firm had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, sell-side analysts predict that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.

Institutional Trading of Tenet Healthcare

Several institutional investors have recently added to or reduced their stakes in THC. NewEdge Advisors LLC increased its position in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after buying an additional 166 shares during the period. Jones Financial Companies Lllp grew its stake in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after acquiring an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new position in Tenet Healthcare during the second quarter worth about $290,000. Quantbot Technologies LP acquired a new stake in Tenet Healthcare in the 2nd quarter worth about $65,000. Finally, Amundi boosted its holdings in Tenet Healthcare by 4,207.8% in the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after purchasing an additional 26,383 shares during the period. 95.44% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on THC shares. Stephens restated an “overweight” rating and set a $285.00 target price on shares of Tenet Healthcare in a report on Monday, July 27th. KeyCorp decreased their price objective on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Wells Fargo & Company upped their target price on shares of Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a report on Monday. Royal Bank Of Canada lifted their price target on Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Monday, July 27th. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Tenet Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $271.00.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.